NCT00386347View on ClinicalTrials.gov

A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

October 31, 2006

Conditions

HIV InfectionInfection, Human Immunodeficiency Virus

Interventions

DRUG

GSK364735 oral solution and oral tablets

Trial Locations (1)

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY